Update on primary mucosal melanoma - 16/07/14
Abstract |
Mucosal melanomas are aggressive cancers of mucosal surfaces with clinical and pathologic characteristics distinct from cutaneous melanomas, warranting different staging systems and treatment approaches. Surgical resection is performed frequently for the primary tumor, although the utility of lymph node surgery and radiation therapy is not established. Therapies targeted against C-KIT activating mutations, identified in many mucosal melanomas, are emerging as promising treatments.
Le texte complet de cet article est disponible en PDF.Key words : anorectal mucosal melanoma, C-KIT inhibitors, clinical characteristics, mucosal melanoma of the head and neck, pathology, urinary tract melanoma, vulvar and vaginal mucosal melanoma, treatment
Abbreviations used : AJCC, APR, CM, CSD, C-KIT, DSS, MM, MMP, MMU, MMAR, MMHN, MMVV, OR, OS, RT, SEER, SLNB, TNM, WLE
Plan
Funding sources: None. |
|
Dr Gerstenblith is an investigator for and has received grants from the Dermatology Foundation and the Char and Chuck Fowler Family Foundation. Ms Bray is a speaker and has received honoraria from Bristol Myers Squibb. Dr Arbesman has received other financial benefits from Elsevier. |
Vol 71 - N° 2
P. 366-375 - août 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?